Ahmed Ali Alghamdi

Health economics & academic expert with 18+ years of experience shaping evidence-based healthcare decision-making across academia, regulation, and advisory roles. I operate at the intersection of strategy, policy, and economic evaluation—translating complex data into high-level decisions that influence pricing, reimbursement, and national healthcare priorities. I currently serve as an associate professor of health economics and chairman of the Clinical Pharmacy Department. Throughout my career, I have led large-scale economic burden studies, cost-effectiveness analyses, and value-based healthcare initiatives across cardiovascular disease, oncology, and autoimmune disorders. My expertise spans Health Technology Assessment (HTA), market access strategy, real-world evidence generation, advanced economic modelling, and strategic advisory to decision-makers. I have built research capabilities, directed academic programmes, led multidisciplinary teams, and collaborated with regulators, healthcare systems, and industry stakeholders.